Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Jul-24 5:54 PM View:  | Clifton R. Laduane CFO & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 17-Jul-24 | Private Purchase | 2,000 | $6.77 | $13,540.00 | 12% 16.47K to 18.47K | |
| 16-Jul-24 10:00 PM View: | Anderson Thomas Director | Zevra Therapeutics, Inc. (ZVRA) | 16-Jul-24 | Private Purchase | 10,000 | $6.81 | $68,065.00 | 100% 10.0K to 20.0K | |
| 15-Jul-24 4:10 PM View: | Bode John B Director | Zevra Therapeutics, Inc. (ZVRA) | 12-Jul-24 | Private Purchase | 10,000 | $5.87 | $58,661.00 | 50% 20.0K to 30.0K | |
| 06-Sep-23 4:39 PM View: | Anderson Thomas Director | Zevra Therapeutics, Inc. (ZVRA) | 06-Sep-23 | Private Purchase | 10,000 | $4.88 | $48,764.00 | 100% 0 to 10.0K | |
| 06-Sep-23 5:11 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 06-Sep-23 | Private Purchase | 1,000 | $4.96 | $4,959.10 | 7% 14.31K to 15.31K | |
| 06-Sep-23 5:11 PM View: | Schafer Joshua CCO & EVP, Bus. Development | Zevra Therapeutics, Inc. (ZVRA) | 05-Sep-23 | Private Purchase | 500 | $5.13 | $2,564.50 | 17% 3.0K to 3.5K | |
| 06-Sep-23 4:40 PM View: | Bode John B Director | Zevra Therapeutics, Inc. (ZVRA) | 05-Sep-23 | Private Purchase | 10,000 | $5.13 | $51,333.00 | 100% 10.0K to 20.0K | |
| 26-Jun-23 4:19 PM View: | Watton Corey Michael Director | Zevra Therapeutics, Inc. (ZVRA) | 23-Jun-23 | Private Purchase | 275 | $5.95 | $1,635.67 | 38% 0.72K to 1.0K | |
| 13-Jun-23 10:00 PM View: | Watton Corey Michael Director | Zevra Therapeutics, Inc. (ZVRA) | 09-Jun-23 | Private Purchase | 325 | $5.52 | $1,794.00 | 41% 0.8K to 1.13K | |
| 31-May-23 11:34 AM View: | Watton Corey Michael Director | Zevra Therapeutics, Inc. (ZVRA) | 30-May-23 | Private Purchase | 400 | $5.11 | $2,042.12 | 100% 0 to 0.4K | |
| 30-Jun-23 4:14 PM View: | Schafer Joshua CCO & EVP, Bus. Development | Zevra Therapeutics, Inc. (ZVRA) | 19-May-23 | Private Purchase | 1,000 | $5.42 | $5,415.70 | 50% 2.0K to 3.0K | |
| 18-May-23 4:56 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 18-May-23 | Private Purchase | 2,740 | $4.95 | $13,561.90 | 25% 11.0K to 13.74K | |
| 19-May-23 5:53 PM View: | Bode John B Director | Zevra Therapeutics, Inc. (ZVRA) | 18-May-23 | Private Purchase | 10,000 | $5.04 | $50,417.70 | 100% 0 to 10.0K | |
| 21-Mar-23 4:32 PM View: | Seymour Tamara A Director | Zevra Therapeutics, Inc. (ZVRA) | 17-Mar-23 | Private Purchase | 519 | $4.82 | $2,502.36 | 260% 0.2K to 0.72K | |
| 15-Mar-23 10:00 PM View: | Schafer Joshua CCO & EVP, Bus. Development | Zevra Therapeutics, Inc. (ZVRA) | 14-Mar-23 | Private Purchase | 2,000 | $4.61 | $9,217.80 | 100% 0 to 2.0K | |
| 13-Mar-23 7:56 AM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 10-Mar-23 | Private Purchase | 1,725 | $4.15 | $7,158.75 | 19% 9.28K to 11.0K | |
| 13-Mar-23 7:57 AM View: | Sangiovanni Timothy J. SVP, Corporate Controller | Zevra Therapeutics, Inc. (ZVRA) | 10-Mar-23 | Private Purchase | 1,200 | $4.14 | $4,967.17 | 37% 3.25K to 4.45K | |
| 13-Mar-23 7:59 AM View: | Plooster Matthew R Director | Zevra Therapeutics, Inc. (ZVRA) | 09-Mar-23 | Private Purchase | 11,000 | $4.20 | $46,148.30 | 121% 9.1K to 20.1K | |
| 13-Mar-23 7:53 AM View: | Pascoe Richard W Chief Executive Officer Director | Zevra Therapeutics, Inc. (ZVRA) | 09-Mar-23 | Private Purchase | 10,000 | $4.20 | $41,978.00 | 50% 19.97K to 29.97K | |
| 13-Mar-23 7:54 AM View: | Tierney David S Director | Zevra Therapeutics, Inc. (ZVRA) | 09-Mar-23 | Private Purchase | 5,000 | $4.15 | $20,731.50 | 86% 5.83K to 10.84K | |
| 13-Jan-23 5:28 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 13-Jan-23 | Private Purchase | 635 | $5.81 | $3,689.82 | 7% 8.64K to 9.28K | |
| 13-Jan-23 5:27 PM View: | Pascoe Richard W Chief Executive Officer Director | Zevra Therapeutics, Inc. (ZVRA) | 13-Jan-23 | Private Purchase | 9,500 | $5.44 | $51,679.10 | 91% 10.47K to 19.97K | |
| 03-Oct-22 7:57 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 30-Sep-22 | Private Purchase | 1,000 | $5.98 | $5,981.20 | 14% 7.11K to 8.11K | |
| 25-May-22 9:03 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 25-May-22 | Private Purchase | 3,000 | $4.37 | $13,096.00 | 2% 158.77K to 161.77K | |
| 26-May-22 8:30 PM View: | Tierney David S Director | Zevra Therapeutics, Inc. (ZVRA) | 25-May-22 | Private Purchase | 2,000 | $4.39 | $8,780.00 | 52% 3.83K to 5.83K | |
| 25-May-22 9:03 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 25-May-22 | Purchase | 10,000 | $4.39 | $43,900.00 | 6% 161.77K to 171.77K | |
| 24-May-22 8:58 PM View: | Seymour Tamara A Director | Zevra Therapeutics, Inc. (ZVRA) | 20-May-22 | Private Purchase | 200 | $4.87 | $974.00 | 100% 0 to 0.2K | |
| 18-May-22 5:17 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 18-May-22 | Private Purchase | 1,200 | $5.00 | $5,999.04 | 23% 5.24K to 6.44K | |
| 18-May-22 5:25 PM View: | Pascoe Richard W Executive Chairman Director | Zevra Therapeutics, Inc. (ZVRA) | 18-May-22 | Private Purchase | 5,000 | $4.92 | $24,607.60 | 152% 3.29K to 8.29K | |
| 18-May-22 7:01 PM View: | Plooster Matthew R Director | Zevra Therapeutics, Inc. (ZVRA) | 18-May-22 | Private Purchase | 5,000 | $4.96 | $24,780.30 | 122% 4.1K to 9.1K | |
| 01-Dec-21 4:28 PM View: | Plooster Matthew R Director | Zevra Therapeutics, Inc. (ZVRA) | 01-Dec-21 | Grant | 2,500 | $8.44 | $21,100.00 | 156% 1.6K to 4.1K | (7%) |
| 30-Nov-21 7:42 PM View: | Pascoe Richard W Executive Chairman Director | Zevra Therapeutics, Inc. (ZVRA) | 30-Nov-21 | Market Purchase | 1,500 | $7.88 | $11,822.10 | 84% 1.78K to 3.29K | (< 1%) |
| 30-Nov-21 4:10 PM View: | Tierney David S Director | Zevra Therapeutics, Inc. (ZVRA) | 30-Nov-21 | Market Purchase | 2,000 | $7.79 | $15,578.00 | 109% 1.83K to 3.83K | < 1% |
| 18-Nov-21 4:57 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 18-Nov-21 | Market Purchase | 510 | $8.29 | $4,227.90 | 11% 4.73K to 5.24K | < 1% |
| 23-Nov-21 4:03 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 18-Nov-21 | Market Purchase | 2,250 | $8.23 | $18,516.40 | 1% 156.52K to 158.77K | (1%) |
| 29-Sep-21 4:10 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 29-Sep-21 | Market Purchase | 215 | $9.38 | $2,016.70 | 5% 4.51K to 4.73K | (2%) |
| 20-Sep-21 5:03 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 20-Sep-21 | Market Purchase | 935 | $8.59 | $8,028.38 | 26% 3.58K to 4.51K | 6% |
| 01-Sep-21 4:04 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 01-Sep-21 | Market Purchase | 230 | $9.10 | $2,094.15 | 7% 3.35K to 3.58K | 2% |
| 30-Aug-21 5:09 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 30-Aug-21 | Market Purchase | 5,000 | $8.92 | $44,607.50 | 3% 151.52K to 156.52K | (< 1%) |
| 24-Aug-21 4:51 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 24-Aug-21 | Acquisition (other) | 9,042 | -- | -- | 4% 257.09K to 266.13K | |
| 24-Aug-21 4:51 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 24-Aug-21 | Disposition (other) | 9,412 | -- | -- | (6%) 160.94K to 151.52K | |
| 24-Aug-21 4:51 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 24-Aug-21 | Disposition (other) | 96,153 | -- | -- | (36%) 266.13K to 169.98K | |
| 24-Aug-21 4:51 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 24-Aug-21 | Acquisition (other) | 96,153 | -- | -- | 60% 160.94K to 257.09K | |
| 24-Aug-21 4:51 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 24-Aug-21 | Disposition (other) | 9,042 | -- | -- | (5%) 169.98K to 160.94K | |
| 24-Jun-21 4:22 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 23-Jun-21 | Market Purchase | 75 | $14.11 | $1,058.25 | 2% 3.27K to 3.35K | 1% |
| 14-Jun-21 4:37 PM View: | Mickle Travis C President & CEO Director | Zevra Therapeutics, Inc. (ZVRA) | 14-Jun-21 | Market Purchase | 1,500 | $14.43 | $21,645.00 | < 1% 159.44K to 160.94K | 1% |
| 27-May-21 5:50 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 27-May-21 | Market Purchase | 150 | $9.85 | $1,477.50 | 5% 3.13K to 3.27K | < 1% |
| 17-May-21 4:42 PM View: | Braun Samuel J 10% Owner | Zevra Therapeutics, Inc. (ZVRA) | 13-May-21 | Market Purchase | 10,000 | $8.55 | $85,500.00 | < 1% 3.06M to 3.07M | |
| 26-Aug-20 5:08 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 26-Aug-20 | Private Purchase | 1,000 | $0.84 | $839.00 | 2% 49.0K to 50.0K | |
| 18-Aug-20 4:48 PM View: | Clifton R. Laduane CFO, Secretary & Treasurer | Zevra Therapeutics, Inc. (ZVRA) | 18-Aug-20 | Private Purchase | 2,000 | $0.69 | $1,390.00 | 4% 47.0K to 49.0K |
